Glucocorticoids for acute viral bronchiolitis in infants and young children
- 4 June 2013
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2013 (6), CD004878
- https://doi.org/10.1002/14651858.cd004878.pub4
Abstract
Background Previous systematic reviews have not shown clear benefit of glucocorticoids for acute viral bronchiolitis, but their use remains considerable. Recent large trials add substantially to current evidence and suggest novel glucocorticoid‐including treatment approaches. Objectives To review the efficacy and safety of systemic and inhaled glucocorticoids in children with acute viral bronchiolitis. Search methods We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2012, Issue 12), MEDLINE (1950 to January week 2, 2013), EMBASE (1980 to January 2013), LILACS (1982 to January 2013), Scopus® (1823 to January 2013) and IRAN MedEx (1998 to November 2009). Selection criteria Randomised controlled trials (RCTs) comparing short‐term systemic or inhaled glucocorticoids versus placebo or another intervention in children under 24 months with acute bronchiolitis (first episode with wheezing). Our primary outcomes were: admissions by days 1 and 7 for outpatient studies; and length of stay (LOS) for inpatient studies. Secondary outcomes included clinical severity parameters, healthcare use, pulmonary function, symptoms, quality of life and harms. Data collection and analysis Two authors independently extracted data on study and participant characteristics, interventions and outcomes. We assessed risk of bias and graded strength of evidence. We meta‐analysed inpatient and outpatient results separately using random‐effects models. We pre‐specified subgroup analyses, including the combined use of bronchodilators used in a protocol. Main results We included 17 trials (2596 participants); three had low overall risk of bias. Baseline severity, glucocorticoid schemes, comparators and outcomes were heterogeneous. Glucocorticoids did not significantly reduce outpatient admissions by days 1 and 7 when compared to placebo (pooled risk ratios (RRs) 0.92; 95% confidence interval (CI) 0.78 to 1.08 and 0.86; 95% CI 0.7 to 1.06, respectively). There was no benefit in LOS for inpatients (mean difference ‐0.18 days; 95% CI ‐0.39 to 0.04). Unadjusted results from a large factorial low risk of bias RCT found combined high‐dose systemic dexamethasone and inhaled epinephrine reduced admissions by day 7 (baseline risk of admission 26%; RR 0.65; 95% CI 0.44 to 0.95; number needed to treat 11; 95% CI 7 to 76), with no differences in short‐term adverse effects. No other comparisons showed relevant differences in primary outcomes. Authors' conclusions Current evidence does not support a clinically relevant effect of systemic or inhaled glucocorticoids on admissions or length of hospitalisation. Combined dexamethasone and epinephrine may reduce outpatient admissions, but results are exploratory and safety data limited. Future research should further assess the efficacy, harms and applicability of combined therapy.This publication has 169 references indexed in Scilit:
- Controversies in the Treatment of the Acutely Wheezing InfantAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Can we rely on the best trial? A comparison of individual trials and systematic reviewsBMC Medical Research Methodology, 2010
- Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezingJournal of Allergy and Clinical Immunology, 2008
- Wheezing Rhinovirus Illnesses in Early Life Predict Asthma Development in High-Risk ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Viral and Host Factors in Human Respiratory Syncytial Virus PathogenesisJournal of Virology, 2008
- A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroidsBritish Journal of Pharmacology, 2008
- Usefulness of Systematic Review Search Strategies in Finding Child Health Systematic Reviews in MEDLINEArchives of Pediatrics & Adolescent Medicine, 2008
- Acute bronchiolitisBMJ, 2007
- The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virusEpidemiology and Infection, 2007